You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 4, April 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 13TH ANNUAL MEETING OF THE ASSOCIATION OF VETERANS ADMINISTRATION SURGEONS, MAY 4 TO MAY 6, 1989, SAN ANTONIO, TEX
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Cause of Coagulopathy After Peritoneovenous Shunt for Malignant Ascites

John J. Gleysteen, MD; Clara V. Hussey, MD; Margaret G. Heckman, MD

Arch Surg. 1990;125(4):474-477.


Abstract

• Thirty-five patients with malignant ascites who received a peritoneovenous shunt were studied to determine the type and duration of postoperative coagulopathy. Coagulation factors were measured before and on the first and third day after the placement of a Denver peritoneovenous shunt; 1 to 10 L of ascites was removed at operation. Levels of platelets, antithrombin III, plasminogen, antiplasmin, fibrinogen, and factors V and VIII decreased by the first postoperative day but did not change further through the third day. The levels of fibrinolytic split products increased on day 1 but were lower by day 3. The platelet count reduction by the third day correlated with the hematocrit change (-0.031). The prothrombin and activated partial thromboplastin times remained normal postoperatively. The patterns of change were similar for patients with positive (n=18) and negative (n = 17) ascites cytologic findings, with elevated (n = 24) and normal (n = 11) preoperative fibrinolytic split product levels, an elevated bilirubin value (25 µmol/L; n=9), and no jaundice (n = 26). Bleeding did not occur. The data indicated that plasminogen- rather than thromboplastin-activated fibrinolysis occurred and that platelet reduction was largely dilutional. The reactions were not progressive when ascites was removed operatively.

(Arch Surg. 1990;125:474-477)



Author Affiliations

From the Surgical (Dr Gleysteen) and Laboratory (Dr Heckman) Services, Zablocki Veterans Administration Medical Center, Milwaukee, Wis, and the Departments of Surgery (Dr Gleysteen) and Pathology (Dr Hussey), Medical College of Wisconsin, Milwaukee. Dr Gleysteen is now with the Veterans Administration Medical Center, Birmingham, Ala.


Footnotes

Accepted for publication August 11, 1989.

Read before the 13th Annual Meeting of the Association of Veterans Administration Surgeons, San Antonio, Tex, May 4, 1989.

Reprint requests to Surgical Service, Veterans Administration Medical Center, 700 S 19th St, Birmingham, AL 35233 (Dr Gleysteen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.